GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,086,000 | +14.2% | 26,541 | +6.1% | 0.04% | -7.9% |
| Q1 2020 | $951,000 | -11.0% | 25,012 | +10.3% | 0.04% | +15.2% |
| Q4 2019 | $1,068,000 | +24.8% | 22,686 | +13.4% | 0.03% | +13.8% |
| Q3 2019 | $856,000 | +15.4% | 20,013 | +8.3% | 0.03% | +7.4% |
| Q2 2019 | $742,000 | -4.5% | 18,476 | -0.2% | 0.03% | -6.9% |
| Q1 2019 | $777,000 | -1.4% | 18,512 | -9.9% | 0.03% | -17.1% |
| Q4 2018 | $788,000 | -21.0% | 20,548 | -16.9% | 0.04% | -2.8% |
| Q3 2018 | $997,000 | -4.6% | 24,726 | -4.2% | 0.04% | -10.0% |
| Q2 2018 | $1,045,000 | +1.5% | 25,814 | -1.6% | 0.04% | 0.0% |
| Q1 2018 | $1,030,000 | +42.3% | 26,231 | +28.9% | 0.04% | +42.9% |
| Q4 2017 | $724,000 | -14.8% | 20,354 | -2.5% | 0.03% | -20.0% |
| Q3 2017 | $850,000 | +57.4% | 20,875 | +67.3% | 0.04% | +40.0% |
| Q2 2017 | $540,000 | – | 12,477 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |